Leaflet TAMOXIFEN SANDOZ 10mg film-coated tablets

Product code:
W53654002
Quantity:
100
Indicated for:
breast cancer
Route of administration:
oral
Substance:
tamoxifen (selective estrogen receptor modulator)
ATC
L02BA01 — Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-estrogens
Tamoxifen is a medication primarily used for the treatment and prevention of breast cancer, particularly hormone-sensitive forms (estrogen receptor-positive). It is a selective estrogen receptor modulator (SERM) that works by blocking the effects of estrogen on breast cells, thereby reducing the growth and spread of cancer cells.

Tamoxifen is used in the treatment of early-stage breast cancer, as well as advanced or metastatic cases. It is also prescribed to reduce the risk of breast cancer recurrence and to prevent breast cancer in women at high risk.

Side effects may include hot flashes, nausea, fatigue, vaginal dryness, mood changes, and, in rare cases, blood clots or endometrial cancer. It is important to take tamoxifen as prescribed by a doctor, with regular monitoring to detect potential complications.

General data about TAMOXIFEN SANDOZ 10mg

Substance:
tamoxifen
Date of latest medicines list:
01-06-2026
Product code:
W53654002
Concentration:
10mg
Pharmaceutical form:
film-coated tablets
Quantity:
100
Product type:
Generic medicine
Price:
44.66 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
SALUTAS PHARMA GMBH - GERMANIA
Holder:
HEXAL AG - GERMANIA
Number:
2715/2010/02
Shelf life:
5 years

Pharmaceutical forms available for tamoxifen

Concentrations available for tamoxifen

  • 10mg
  • 20mg
  • 30mg
  • 40mg

Compensation lists for TAMOXIFEN SANDOZ 10mg Hexal

NHP 3 (C2) - NHP oncology

Price
44.66 RON
Copayment
44.66 RON
Patient
0.00 RON